These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34824689)

  • 1. Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting.
    Sovic W; Mathew C; Blough B; Monday KA; Sam T; Zafar H; Guerrero-Miranda C; Sherwood M; Hebert C; Hall S; Alam A
    Methodist Debakey Cardiovasc J; 2021; 17(4):98-101. PubMed ID: 34824689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
    Cutler NS; Rasmussen BM; Bredeck JF; Lata AL; Khanna AK
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2756-2762. PubMed ID: 32868151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device.
    Sacks LD; Hollander SA; Zhang Y; Ryan KR; Ford MA; Maeda K; Murray JM; Almond CS; Kwiatkowski DM
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2433-2440. PubMed ID: 30929985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoplegia from Continuous Flow Left Ventricular Assist Devices.
    Sathianathan S; Bhat G; Dowling R
    Curr Cardiol Rep; 2021 Jul; 23(8):101. PubMed ID: 34196837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin Complex Concentrate and Methylene Blue for Treatment of Coagulopathy and Vasoplegia in a Pediatric Heart Transplant Patient.
    Lee JK; Ing C
    A A Case Rep; 2016 Mar; 6(5):127-9. PubMed ID: 26599739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Vasoplegic Shock After Heart Transplant Successfully Treated With Multimodal Therapeutic Approach.
    Jenkins FS; Aubin H; Boeken U; Lichtenberg A
    Exp Clin Transplant; 2024 May; 22(5):406-408. PubMed ID: 38970287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology.
    Wieruszewski PM; Sims CR; Daly RC; Taner T; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2366-2367. PubMed ID: 31076311
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes.
    Batchelor RJ; Wong N; Liu DH; Chua C; William J; Tee SL; Sata Y; Bergin P; Hare J; Leet A; Taylor AJ; Patel HC; Burrell A; McGiffin D; Kaye DM
    J Card Fail; 2022 Apr; 28(4):617-626. PubMed ID: 34974975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
    Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoplegia in patients following ventricular assist device explant and heart transplantation.
    Emmanuel S; Pearman M; Jansz P; Hayward CS
    Perfusion; 2022 Mar; 37(2):152-161. PubMed ID: 33482711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoplegia: A Review.
    Ratnani I; Ochani RK; Shaikh A; Jatoi HN
    Methodist Debakey Cardiovasc J; 2023; 19(4):38-47. PubMed ID: 37547893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.
    Patarroyo M; Simbaqueba C; Shrestha K; Starling RC; Smedira N; Tang WH; Taylor DO
    J Heart Lung Transplant; 2012 Mar; 31(3):282-7. PubMed ID: 22112993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation.
    Saha A; Jennings DL; Ning Y; Kurlansky P; Miltiades AN; Spellman JL; Sanchez J; Yuzefpolskaya M; Colombo PC; Takayama H; Naka Y; Takeda K
    Ann Thorac Surg; 2021 Mar; 111(3):800-808. PubMed ID: 32758558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARNI Pre-Operative Use and Vasoplegic Syndrome in Patients Undergoing Heart Transplantation or Left Ventricular Assist Device Surgery.
    Haider L; Hugon-Vallet E; Constantin JP; Riad Z; Sebbag L; Mewton N
    Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076588
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.
    Truby LK; Takeda K; Farr M; Beck J; Yuzefpolskaya M; Colombo PC; Topkara VK; Mancini D; Naka Y; Takayama H
    ASAIO J; 2018; 64(1):43-51. PubMed ID: 28777136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Management of Vasoplegia in Temporary Mechanical Circulatory Support: A Narrative Review.
    Ortoleva J; Dalia AA; Pisano DV; Shapeton A
    J Cardiothorac Vasc Anesth; 2024 Jun; 38(6):1378-1389. PubMed ID: 38490900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
    Chow JH; Strauss E; Mazzeffi MA
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):59-60. PubMed ID: 32950345
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin-II for vasoplegia following cardiac surgery.
    Johnson AJ; Tidwell W; McRae A; Henson CP; Hernandez A
    Perfusion; 2024 Nov; 39(8):1676-1684. PubMed ID: 37955639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
    Papazisi O; Palmen M; Danser AHJ
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.